Early morbidity after pancreas transplantation

被引:8
作者
Bindi, ML
Biancofiore, G
Meacci, L
Bellissima, G
Nardi, S
Pieri, M
Vistoli, F
Boggi, U
Sansevero, A
Mosca, F
机构
[1] Univ Pisana, Osped Cisanello, Unita Terapia Intens Postchirug & Trapianti, Pisa, Italy
[2] Univ Pisa, UO Chirurg Gen & Trapianti, Pisa, Italy
关键词
intensive care unit; pancreas transplantation; postoperative complications; treatment outcome;
D O I
10.1111/j.1432-2277.2005.00222.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study aims to evaluate and compare the early outcome of both pancreas-alone transplantation (PTA) and simultaneous kidney-pancreas transplantation (SPKT) focusing on the complications affecting the first month after the procedures. The records of all patients who underwent PTA or SPKT were reviewed. We considered the length of ICU stay, the need for postoperative ventilatory support, hemodynamic and metabolic data (arterial pH, serum glucose, need for exogenous insulin), infectious diseases incidence, microbiological colonization rate and any kind of postoperative complication arising during the first month after the transplantation. PTA recipients underwent a quicker surgery (P < 0.01) with shorter ICU stay (P < 0.05) and a lower need for postoperative mechanical ventilation (P < 0.05). They also had a higher hemodynamic stability (P < 0.05) with less cardiological complications (P < 0.05) in the intra- and postoperative phases; bacterial colonisation was also less frequent in PTA recipients (P < 0.05). On the contrary, no significant difference was noted with regard to postoperative nausea/vomiting, sudden myocardial death, ICU re-admissions, graft function, rate of rejection, grafts explantation and re-transplantation. PTA could be considered as preemptive for severe diabetic complications in patients with long-lasting severe type I diabetes. However, establishing the correct timing of PTA is of paramount importance in order not to expose the patients early to risks arising from a major surgery and heavy immunosuppressive treatments.
引用
收藏
页码:1356 / 1360
页数:5
相关论文
共 16 条
  • [1] Becker BN, 2001, J AM SOC NEPHROL, V12, P2517, DOI 10.1681/ASN.V12112517
  • [2] Bindi M L, 2005, Minerva Anestesiol, V71, P207
  • [3] BLOOM RD, 1997, TRANSPLANTATION, V64, P1685
  • [4] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [5] Appropriateness and timing of kidney and/or pancreas transplants in type 1 and type 2 diabetes
    Friedman, AL
    [J]. ADVANCES IN RENAL REPLACEMENT THERAPY, 2001, 8 (01): : 70 - 82
  • [6] Mortality assessment for pancreas transplants
    Gruessner, RWG
    Sutherland, DER
    Gruessner, AC
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) : 2018 - 2026
  • [7] Harper SJ, 1996, TRANSPLANT INT, V9, P115, DOI 10.1007/BF00336388
  • [8] Decreased surgical risks of pancreas transplantation in the modern era
    Humar, A
    Kandaswamy, R
    Granger, D
    Gruessner, RW
    Gruessner, AC
    Sutherland, DER
    [J]. ANNALS OF SURGERY, 2000, 231 (02) : 269 - 275
  • [9] Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: A theoretical analysis
    Kiberd, BA
    Larson, T
    [J]. TRANSPLANTATION, 2000, 70 (07) : 1121 - 1127
  • [10] KOHNTOP DE, 1998, KIDNEY TRANSPLANTATI, P253